Aldara - Imiquimod 5% + IDH1R132H-vac + Vorasidenib hemicitric acid hemihydrate

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Aldara - Imiquimod 5% + IDH1R132H-vac + Vorasidenib hemicitric acid hemihydrate
Treatment and conditionWhere it standsTrials
Aldara - Imiquimod 5% + IDH1R132H-vac + Vorasidenib hemicitric acid hemihydrate for astrocytomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1